This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Discover where to find the best rewards credit cards and start maximizing your rewards potential. Explore your options today.
14,531 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Insider trades can hint at a company's future, but not every move is meaningful. This article shows how to filter sig...
Two widely watched real estate ETFs take different paths to property exposure. This gqre icf: matchup real guide comp...
Friday marks the first triple witching of 2026 as Iran tensions flare, prompting investors to brace for volatile move...
A headline-grabbing $60 million deal with Harry and Meghan raised questions about value, expectations, and how to mea...
The Trade Desk just fell to a multi-year low, sparking a debate between momentum fans and value hunters. This guide b...
A sudden disruption to helium from Qatar is reverberating through semiconductor and AI hardware supply chains. With Q...
With a funding deadlock gripping the federal government, Trump’s border czar says ICE could be deployed to airport sc...
Copper demand is surging as data centers, EVs, and renewables push miners to expand. BHP reorganizes around copper, w...
A pullback in AbbVie has some investors asking if the stock looks like a bargain. This guide explains why that view m...
A modular housing developer is pushing into dense city towers, pairing off-site production with new financing models ...
Arm is venturing into silicon design after decades as a licensing powerhouse. This bold shift could impact AI data ce...